CA3197232A1 — Surface acoustic wave atomizer with fluid direction and migration prevention
Assigned to Trudell Medical International · Expires 2022-05-12 · 4y expired
What this patent protects
A surface acoustic wave (SAW) atomizer system for use in providing a nebulized medicament to a patient is described. The system may include a SAW atomization engine with an atomization region on a substrate that is separated from the interdigitated transducers (IDTs) on the subst…
USPTO Abstract
A surface acoustic wave (SAW) atomizer system for use in providing a nebulized medicament to a patient is described. The system may include a SAW atomization engine with an atomization region on a substrate that is separated from the interdigitated transducers (IDTs) on the substrate by a fluid barrier that seals off liquid fed into the atomization region from the adjacent IDTs and electrical contacts driving the IDTs.
Drugs covered by this patent
- glycopyrrolate (Glycopyrrolate) · Yonsei University
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.